{"Abstract": [0], "Adeno-associated": [1], "virus": [2], "(AAV)": [3], "has": [4, 33, 62], "emerged": [5], "as": [6, 41, 49, 56, 100, 145, 147], "a": [7, 42, 57, 181], "pivotal": [8], "delivery": [9], "tool": [10, 43], "in": [11, 27, 91, 132, 176], "clinical": [12, 134], "gene": [13, 25, 72, 194], "therapy": [14, 73], "owing": [15], "to": [16, 22, 82, 163], "its": [17], "minimal": [18], "pathogenicity": [19], "and": [20, 39, 96, 105, 122, 142, 160, 173, 186], "ability": [21], "establish": [23], "long-term": [24], "expression": [26], "different": [28], "tissues.": [29], "Recombinant": [30], "AAV": [31, 112], "(rAAV)": [32], "been": [34], "engineered": [35], "for": [36, 44, 65, 136, 184], "enhanced": [37], "specificity": [38], "developed": [40], "treating": [45], "various": [46], "diseases.": [47], "However,": [48], "rAAV": [50], "is": [51], "being": [52, 130], "more": [53], "widely": [54], "used": [55], "therapy,": [58], "the": [59, 66, 177, 189], "increased": [60], "demand": [61], "created": [63], "challenges": [64, 175], "existing": [67], "manufacturing": [68, 123], "methods.": [69], "Seven": [70], "rAAV-based": [71, 193], "products": [74], "have": [75], "received": [76], "regulatory": [77], "approval,": [78], "but": [79], "there": [80], "continue": [81], "be": [83, 180], "concerns": [84], "about": [85], "safely": [86], "using": [87], "high-dose": [88], "viral": [89], "therapies": [90], "humans,": [92], "including": [93], "immune": [94, 151], "responses": [95, 152], "adverse": [97], "effects": [98], "such": [99], "genotoxicity,": [101], "hepatotoxicity,": [102], "thrombotic": [103], "microangiopathy,": [104], "neurotoxicity.": [106], "In": [107], "this": [108], "review,": [109], "we": [110], "explore": [111], "biology": [113], "with": [114], "an": [115], "emphasis": [116], "on": [117], "current": [118, 174], "vector": [119], "engineering": [120], "strategies": [121, 162], "technologies.": [124], "We": [125, 149, 167], "discuss": [126, 161], "how": [127], "rAAVs": [128], "are": [129], "employed": [131], "ongoing": [133], "trials": [135], "ocular,": [137], "neurological,": [138], "metabolic,": [139], "hematological,": [140], "neuromuscular,": [141], "cardiovascular": [143], "diseases": [144], "well": [146], "cancers.": [148], "outline": [150], "triggered": [153], "by": [154], "rAAV,": [155], "address": [156], "associated": [157], "side": [158], "effects,": [159], "mitigate": [164], "these": [165], "reactions.": [166], "hope": [168], "that": [169], "discussing": [170], "recent": [171], "advancements": [172], "field": [178], "will": [179], "helpful": [182], "guide": [183], "researchers": [185], "clinicians": [187], "navigating": [188], "ever-evolving": [190], "landscape": [191], "of": [192], "therapy.": [195]}